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Abstract
Background: Porphyromonas gingivalis is a major pathogen of periodontal disease that affects a majority of adults
worldwide. Increasing evidence shows that periodontal disease is linked to various systemic diseases like diabetes and
cardiovascular disease, by contributing to increased systemic levels of inflammation. Lipopolysaccharides (LPS), as a key
virulent attribute of P. gingivalis, possesses significant amount of lipid A heterogeneity containing tetra- (LPS1435/1449) and
penta-acylated (LPS1690) structures. Hitherto, the exact molecular mechanism of P. gingivalis LPS involved in periodontal
pathogenesis remains unclear, due to limited understanding of the specific receptors and signaling pathways involved in
LPS-host cell interactions.
Methodology/Principal Findings: This study systematically investigated the effects of P. gingivalis LPS1435/1449 and LPS1690
on the expression of TLR2 and TLR4 signal transduction and the activation of pro-inflammatory cytokines IL-6 and IL-8 in
human gingival fibroblasts (HGFs). We found that LPS1435/1449 and LPS1690 differentially modulated TLR2 and TLR4
expression. NF-kB pathway was significantly activated by LPS1690 but not by LPS1435/1449. In addition, LPS1690 induced
significant expression of NF-kB and p38 MPAK pathways-related genes, such as NFKBIA, NFKB1, IKBKB, MAP2K4 and MAPK8.
Notably, the pro-inflammatory genes including GM-CSF, CXCL10, G-CSF, IL-6, IL-8 and CCL2 were significantly upregulated
by LPS1690 while down-regulated by LPS1435/1449. Blocking assays confirmed that TLR4-mediated NF-kB signaling was vital in
LPS1690-induced expression of IL-6 and IL-8 in HGFs.
Conclusions/Significance: The present study suggests that the tetra- and penta-acylated lipid A structures of P. gingivalis
LPS differentially activate TLR4-mediated NF-kB signaling pathway, and significantly modulate the expression of IL-6 and IL-
8 in HGFs. The ability to alter the lipid A structure of LPS could be one of the strategies carried-out by P. gingivalis to evade
innate host defense in gingival tissues, thereby contributing to periodontal pathogenesis.
Citation: Herath TDK, Darveau RP, Seneviratne CJ, Wang C-Y, Wang Y, et al. (2013) Tetra- and Penta-Acylated Lipid Structures of Porphyromonas gingivalis LPS
Differentially Activate TLR4-Mediated NF-kB Signal Transduction Cascade and Immuno-Inflammatory Response in Human Gingival Fibroblasts. PLoS ONE 8(3):
e58496. doi:10.1371/journal.pone.0058496
Editor: David M. Ojcius, University of California Merced, United States of America
Received November 13, 2012; Accepted February 5, 2013; Published March 12, 2013
Copyright:  2013 Herath et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the Hong Kong Research Grants Council (HKU766909M, HKU768411M and HKU767512M to LJJ) (http://www.ugc.edu.hk/
eng/rgc/index.htm) and the Modern Dental Laboratory/HKU Endowment Fund to LJJ. The funders had no role in study design, data collection and analysis,
decision to publish or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ljjin@hkucc.hku.hk
Introduction
Periodontal disease is among the most common chronic
infections and inflammatory events in humans, and severe
periodontal disease (periodontitis) is the major cause of tooth loss
in adults globally [1]. Porphyromonas gingivalis is considered a
keystone bacterial pathogen strongly implicated in periodontal
disease [2–4]. It is able to gain access to gingival tissues from
pathogenic plaque biofilm and proliferate in gingival tissue,
resulting in overt and unco-ordinated immuno-inflammatory
response, and thereby leading to destruction of tooth supporting
tissues [5,6]. Lipopolysaccharide (LPS) is a cell wall component of
Gram-negative bacteria including, P. gingivalis. This biomolecule is
considered to be a major nexus for virulence in periodontitis [3,7].
LPS basically consists of three segments with highly variable and
conserved regions [8,9]. They are a phosphorylated glucosamine
disaccharide substituted with fatty acids known as lipid A which
forms the matrix of the outermost membrane leaflet, a highly
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variable O-polysaccharide (O-antigen) and a conserved core
oligosaccharide that links lipid A to the O-polysaccharide Lipid
A section is the ‘bioactive centre’ of LPS, responsible for its
endotoxicity. This is due to the specific and highly sensitive
recognition of lipid A by host cells, which subsequently leads to
strong immuno-inflammatory response [7,9,10].
P. gingivalis releases copious amounts of LPS that penetrates
gingival tissues [11,12] and actively participates in the pathogenic
process of periodontitis [12–14]. Numerous studies in the past
have examined the role of P. gingivalis LPS in periodontal
pathogenesis. However, the precise nature of this relationship
has been obscured due to lack of understanding of the underlying
molecular mechanism of P. gingivalis LPS-host interaction. Some
studies show that P. gingivalis LPS is a potent immune activator
similar to the canonical E. coli LPS, whilst others report it to be
immunologically inert [14,15]. Hence, according to some studies
P. gingivalis LPS induces pro-inflammatory cytokines [16,17]
whereas others argue that it may dampen the cytokine expression
[18,19].
Cell surface receptors and signal transduction pathways
involved in P. gingivalis LPS and host cell interaction is at the
heart of this long-standing debate. Most early studies with
canonical E. coli LPS, containing hexa-acylated lipid A structure,
have shown that E. coli LPS exclusively binds to toll-like receptor-4
(TLR4) [20,21]. Although some claim that E. coli LPS may bind to
TLR2, later studies showed that this was a result of lipoprotein
contamination in LPS, since TLR2 is known to occupy the LPS
ligand [22]. This controversy is further fuelled by the findings on
LPS containing heterogeneous lipid A structures of non-entero-
bacterial species such as, P. gingivalis, Bactereiodes fragilis and
Pseudomonas aeruginosa [23–26]. The common structural variation
occurring in P. gingivalis LPS lipid A is due to the alteration of
number of fatty acid chains attached to core disaccharide, which
results in tetra- and penta-acylated structures [27,28]. Hence, P.
gingivalis LPS possesses lipid A structure containing both tetra-
acylated (PgLPS1435/1449) and penta-acylated forms (PgLPS1690)
compared to the hexa-acylated lipid A of E. coli LPS. Cell surface
receptors and signal transduction pathways involved in host
responses to aforementioned heterogeneous lipid A structures are
the focus of the present study.
The heterogeneous nature of LPS lipid A renders P. gingivalis an
unusual ability to interact with both TLR2 and TLR4, in contrast
to E. coli LPS. Structural variation in lipid A moiety of P. gingivalis
LPS may also differentially activate signal transduction pathways
to elicit various immuno-inflammatory responses. For instance,
hexa-acylated E. coli LPS preferentially activates TLR4-NF-kB
cascade, whereas heterogeneous P. gingivalis LPS may use different
cellular signaling pathways to modulate downstream pro-inflam-
matory cytokines [17,29].
Controversial observations have been reported on P. gingivalis
LPS-induced host response in various cell types that were
investigated [30]. Most of the previous studies on P. gingivalis
LPS have been performed in non-oral cells such as embryonic
kidney cells, umbilical cord vein endothelial cells and monocytes
[28,29,31,32]. Only a few studies have undertaken on the primary
cells of dental origin, which are more likely to interact with P.
gingivalis LPS in clinical situations [33,34]. Human gingival
fibroblasts (HGFs) as the predominant structural cells in human
gingiva represent a viable model to study P. gingivalis LPS-host
interactions Firstly, HGFs express a number of pattern recognition
receptors known to orchestrate immuno-inflammatory response
[35–37]. Secondly, different isoforms of P. gingivalis LPS differently
activate the expression of pro-inflammatory cytokines in HGFs as
shown in our recent study [32]. Thirdly, HGFs play a pivotal role
in the immuno-inflammatory response in the pathogenesis of
periodontal disease [15,38,39].
The present study comprehensively investigated the effects of
lipid A molecular heterogeneity of P. gingivalis LPS on the
expression of TLR 2 and TLR4, downstream signal transduction
and on the activation of pro-inflammatory cytokines in HGFs. P.
gingivalis LPS1435/1449 and LPS1690 differentially modulated TLR2
and TLR4 expression. LPS1690 induced significant expression of
NF-kB and p38 MPAK pathways-related genes as well as multiple
pro-inflammatory genes. TLR4 and NF-kB were significantly
involved in P. gingivalis LPS1690-induced expression of IL-6 and IL-
8. Our findings demonstrate that P. gingivalis LPS with tetra- and
penta-acylated lipid A structures differentially activate TLR4-
mediated NF-kB signaling pathway, and critically modulate
immuno-inflammatory response in HGFs.
Results
P. gingivalis LPS1690 and LPS1435/1449 Differentially
Modulated the Expression of TLR2, TLR4 and MD2
Transcripts in HGFs
HGFs were treated with E. coli LPS and P. gingivalis LPS
(LPS1690 and LPS1435/1449) in both dose- and time-dependent
experiments to examine the transcript expression of TLR2, TLR4,
MD2 and MyD88. Basal expression of both TLR2 and TLR4
could be observed in the untreated cells which was upregulated by
E. coli LPS and P. gingivalis LPS (Figs. 1 and 2). E. coli LPS and P.
gingivalis LPS1690 (not LPS1435/1449) significantly upregulated
TLR4 expression at 0.1 mg/ml or above (Fig. 1.1B), and the
expression level reached the peak at 12 and 24 h, respectively
(Fig. 1.2B). Whereas, P. gingivalis LPS1435/1449 and to a less extent
P. gingivalis LPS1690 significantly enhanced the TLR2 expression
(Fig. 1.1A), and the peak expression was observed at 24 h
(Fig. 1.2A). E. coli LPS significantly upregulated CD14 and LBP
expression (Figs. 1.1C and D). MD2 was significantly upregulated
by both P. gingivalis LPS1690 (not LPS1435/1449) and E. coli LPS
(Figs. 1.1E and 1.2C). Additionally, MyD88 increased markedly by
the stimulation of E. coli LPS and to a much less extent by P.
gingivalis LPS (Figs. 1.1F and 1.2D). Foregoing data demonstrated
that P. gingivalis LPS1690 and LPS1435/1449 could differentially
modulate to a different extent the transcript expression of TLR2,
TLR4 and MD2.
P. gingivalis LPS1690 and LPS1435/1449 Differentially
Modulated the Expression of TLR2 and TLR4 Proteins in
HGFs
Next, in a time-course experiment (5–120 min) the expression of
TLR2 and TLR4 proteins in HGFs was analyzed by western blot.
Both TLR2 and TLR4 proteins were detected in all samples
confirming their basal expression (Fig. 2). P. gingivalis LPS1435/14495
induced the prompt expression of TLR2 protein at 5 and 15 min
(Figs. 2A and D). While there was a cyclic TLR4 expression
pattern in cells treated with P. gingivalis LPS1690 and E. coli LPS,
which was observed at 5, 15 and 120 min, respectively (Figs. 2B, C
and E). These data further demonstrated that the expression of
TLR2 and TLR4 in HGFs was differentially modulated by
heterogeneous lipid A structures of P. gingivalis LPS. The
expression profiles of TLR2 and TLR4 were further examined
by antibody-mediated confocal immuno-fluorescence microscopy.
HGFs showed basal expression of both TLR2 and TLR4.
Whereas, P. gingivalis LPS1435/1449 -upregulated the basal expres-
sion of TLR2 at 6 and 24 h (Figs. 3.1 and S1.1). P. gingivalis
LPS1690-upregulated expression of TLR2 was meager at 6 h
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(Fig. 3.1) and became more prominent at 24 h, and only a scanty
expression was noted in cells treated with E. coli LPS at 24 h (Fig.
S1.1). Relatively prompt and marked expression of TLR4 was
observed in cells treated with PgLPS1690 and E. coli LPS at 6 h
(Fig. 3.2) and to a less extent at 24 h (Fig. S1.2). These findings
were overall consistent with foregoing results (Figs. 1 and 2). No
positive signal was detected in negative controls, suggesting that
the antibodies employed were actually bound to TLR2 and TLR4,
and the non-specific binding or background staining was
negligible.
The Expression Profiles of Genes Associated with TLR
Signal Transduction in HGFs induced by P. gingivalis
LPS1690 and LPS1435/1449
The potential modulation of other molecules involved in P.
gingivalis LPS-induced TLR signaling pathway was analyzed using
PCR gene-array. Both P. gingivalis LPS1690 and LPS1435/1449
significantly upregulated (fold changes $2.0) ELK1, HRAS, IL1B,
TLR4, TLR5, TLR9, TNF, TRAF6 and UBE2N, and down
regulated (fold changes ,0.5) BTK, IL-2, IRAK1, LTA, CD180,
MAPK8IP3, NFKBIL1, SIGIRR, TIRAP, TLR1 and TLR7
(Table S1). Notably, P. gingivalis LPS1690 markedly upregulated
Figure 1. P. gingivalis LPS modulated the transcript expression of cell surface receptors and related co-molecules in HGFs. 1.1. P.
gingivalis (Pg) LPS1690 (PgLPS1690) and LPS1435/1449 (PgLPS1435/1449) differentially modulated the mRNA expression of TLR2 (A), TLR4 (B), CD14 (C), LBP
(D), MD2 (E) and MYD88 (F) mRNAs in the cellular fractions of HGFs in the dose-dependent assay (1 ng/ml to 10 mg/ml) for 24 h. E. coli LPS is used as a
reference. 1.2. P. gingivalis LPS and E. coli LPS upregulated the expression of TLR2 (A), TLR4 (B), MD2 (C) and MYD88 (D) transcripts in the cellular
fractions of HGFs. HGFs were treated with P. gingivalis (Pg) LPS (PgLPS) and E. coli LPS at 1 mg/ml in the time-dependent assay for 2 to 48 h. After LPS
stimulation, the harvested RNAs were subjected to quantitative real-time PCR, and the fold changes in gene expression relative to internal control b-
Actin were quantified as shown in the graphs. The mRNA expression of control was considered as 1. Each bar represents the mean 6SD of three
independent experiments with three replicates. *Significant difference with a p-value ,0.05 as compared with the controls without LPS treatment.
doi:10.1371/journal.pone.0058496.g001
Figure 2. TLR2 and TLR4 protein expression in P. gingivalis LPS- and E. coli LPS-stimulated HGFs. Confluent HGFs were stimulated with P.
gingivalis (Pg) LPS1435/1449 (PgLPS1435/1449) 1435/1449 (A, D and E), PgLPS1690 (B, D and E) and E. coli LPS (C, D and E) (1 mg/mL) at the indicated time
points in the western blot analysis for assay of TLR2 and TLR4 protein expression. 40 mg of homogenized cellular extracts were subjected to SDS-
PAGE and probed with anti TLR2 (1:1000) and anti-TLR4 (1:1000) polyclonal antibodies. Blots were re-probed with tubulin to confirm equal loading in
individual samples. One representative blot was shown from three independent experiments with similar results, TLR2:89 kDa; TLR4:96 kDa; and
Tubulin: 50 kDa. Quantification of band intensities was performed by densitometry analysis using Image J software.
doi:10.1371/journal.pone.0058496.g002
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($3-folds) transcript levels of downstream pro-inflammatory
genes, such as GM-CSF, CXCL10, G-CSF, IL-6, IL-8, CCL2
and TLR4, with reference to the untreated controls (Table 1 and
Fig. S2). Moreover, P. gingivalis LPS1690 induced significant
expression of NF-kB pathway-related genes such as NFKBIA,
NFKB1 and IKBKB as well as p38 MPAK pathway molecules
such as MAP2K4 and MAPK8 (Table 1). Interestingly, the
following genes were differentially up- (fold changes from 2.26 to
26.77) or down-regulated (fold changes from 0.06 to 0.67) by the
two isoforms of P. gingivalis (LPS1690 v.s. LPS1435/1449), respectively:
GM-CSF (26.77 v.s. 0.28), CXCL10 (17.27 vs. 0.21), G-CSF
(14.91 vs. 0.67), IL-6 (11.93 vs. 0.06), IL-8 (8.64 vs. 0.35), CCL2
(3.25 vs. 0.58) and CD14 (2.26 vs. 0.45). To confirm some of the
strongly upregulated pro-inflammatory cytokine and chemokine
genes ($3-folds) by P. gingivalis LPS1690, the expression of GM-
CSF, CXCL10, IL- 6 and IL- 8 transcripts were further validated
by real-time qPCR (Fig. S3).
P. gingivalis LPS1690 and LPS1435/1449 Differentially
Determined the Activation of Intracellular Signal
Transduction Pathways
The activation of NF-kB and MAPK signal pathways were
examined by western blot in HGFs in response to the different
isoforms of P. gingivalis LPS1690 and LPS1435/1449. As shown in
Fig. 4, P. gingivalis LPS1690 and E. coli LPS induced the
phosphorylation of IkBa and the p65 subunit of NF-kB. Both
induced intense phosphorylation of IkBa after 15 min stimulation,
which remained to be activated at 120 min (Figs. 4.1B–D).
Comparably, P. gingivalis LPS1435/1449 induced only a weak
activation of IkBa (Fig. 4.1A and D). There was a considerable
level of constitutive expression of phosphorylated p65 in HGFs
and the upregulation of p-p65 was marginal. However, activation
of p65 subunit was observed promptly after 5 min stimulation of P.
gingivalis LPS1690 and 30 min stimulation of E. coli LPS (Figs. 4.2B–
D). No significant phosphorylation of p65 was activated by P.
gingivalis LPS1435/1449 (Fig. 4.2A). Both P. gingivalis LPS1690 and
LPS1435/1449 as well as E. coli LPS induced phosphorylation of p38
MAPK (Figs. 5.1A–C). P. gingivalis LPS1690 activated p38 MAPK
at 15 min which lasted consistently until 120 min (Figs. 5.1B and
D). Whereas, P. gingivalis LPS1435/1449 promptly activated the
phosphoryaltion of p38 MAPK at 5 min and it remained
significant until 120 min (Figs. 5.1A and D). Both P. gingivalis
LPS and E. coli LPS activated ERK1/2 in a similar manner
(Figs. 5.2). On the other hand, SAPK/JNK was not significantly
activated by P. gingivalis LPS and E. coli LPS (Fig. 5.3). Similarly,
there was no significant activation of AKT pathway upon
stimulation with the two isoforms of P. gingivalis LPS (Figs. S4 A,
B and D). In contrast, E. coli LPS significantly induced AKT
phosphorylation at 30 min (Figs. S4 C and D). These data
demonstrated that the structural heterogeneity of P. gingivalis LPS
could determine the activation of signal transduction pathways in
HGFs. Hence, penta-acylated P. gingivalis LPS1690 significantly
activated NF-kB, p38 MAPK and ERK1/2 signals, but not the
Figure 3. Confocal images showing positive TLR2 (3.1) and TLR4 (3.2) expression, in HGFs, following LPS stimulation. The cells were
left untreated (A) or stimulated with P. gingivalis (Pg) LPS1435/1449 (PgLPS1435/1449) (B) PgLPS1690 (C) and E. coli LPS (D) at 1 mg/ml for 6 h. Cells were
permeabilized with 0.1% Triton X-100 and subsequently stained with primary antibodies against TLR2, TLR4 and the correspondent secondary
antibody labeled Alexa fluor 488 anti-rabbit, and subsequently stained with alexa fluor 555 phalloidin for F-actin. Merged images present the
combined TLR2/TLR4, F-actin and nuclear staining (DAPI). Negative control: E. One representative experiment from three independent experiments is
shown. Bar = 50 mm.
doi:10.1371/journal.pone.0058496.g003
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SAPK/JNK and AKT pathways. Similarly, the hexa-acylated E.
coli LPS activated all aforementioned signaling pathways other
than SAPK/JNK. In contrast, tetra-acylated P. gingivalis LPS1435/
1449 predominately activated p38 MAPK and ERK1/2 signals, but
did not strongly induce the NF-kB pathway.
P. gingivalis LPS1690 Induced p-p65-NF-kB Nuclear
Translocation in HGFs
Nuclear translocation of phospho-NF-kB p65 was observed
using confocal immuno-fluorescence microscopy. p-p65-NF-kB
translocation was prominent in P. gingivalis LPS1690-treated cells as
compared with both untreated control and P. gingivalis LPS1435/
1449 (Fig. 6). At the early stage (15 min), p65 was mainly present in
the cytoplasm, and the subsequent translocation took place within
60 min following P. gingivalis LPS1690 stimulation (Figs. 6.1 and
6.2). In the normal condition, p65-NF-kB is retained in the cytosol
in an inactive state being complexed with the inhibitory protein
IkBa. However, upon stimulation with LPS, p-p65-NF-kB
translocates to the nucleus following the gradual degradation of
IkBa. Here we observed that p65-NF-kB was evenly distributed in
the cytoplasm in untreated control cells without the sign of p65
immunoreactivity (Fig. 6.1A). However, nuclear expression of p-
p65-NF-kB observed in controls after 60 min could be due to the
increased intensity with longer exposure time rather than the
translocation (Fig. 6.2A). Following the stimulation with P. gingivalis
LPS1690 and E. coli LPS for 15 min, p-p65-NF-kB started to
migrate to the perinuclear area and the translocation was
completed within 60 min (Figs. 6.1C & D and 6.2C & D). These
data suggested that P. gingivalis LPS1690 could induce the nuclear
translocation of p-p65 which could be important for the optimal
transcription of NF-kB dependent genes.
Functional Involvement of TLR2 and TLR4 in P. gingivalis
LPS1690-induced Expression of IL-6 and IL-8
Blocking assays were used to determine the functional
involvement of TLR2 and TLR4 in P. gingivalis LPS – HGFs
interactions by measuring the expression of downstream cytokines
such as, IL-6 and IL-8. We previously demonstrated that P.
gingivalis LPS1690 (not P. gingivalis LPS1435/1449) and E. coli LPS
induced significant expression of IL-6 and IL-8 in HGFs [33].
Blockage of TLR4 significantly inhibited the P. gingivalis LPS1690-
and E. coli LPS-induced expression of IL-6 and IL-8 mRNAs
(Fig.7.1) and proteins (Fig. 7.2). Whereas, blockage of TLR2 led to
significant inhibition of P. gingivalis LPS1690-induced expression of
IL-6 mRNA and protein (Figs. 7.1A and 7.2A), as well as IL-8
mRNA (Fig. 7.1B). It could therefore be assumed that P. gingivalis
LPS1690 may induce the expression of pro-inflammatory cytokines
like IL-6 via both TLR2 and TLR4, which may be in a way
different from E. coli LPS with its hexa-acylated lipid A structure.
NF-kB Pathway Played a Crucial Role in P. gingivalis
LPS1690-induced Expression of IL-6 and IL-8 in HGFs
Pathway-specific blocking assays further determined the in-
volvement of signal transduction pathways in P. gingivalis LPS-
induced IL-6 and IL-8 expression in HGFs. Specific kinase
inhibitors were used, including IKK-b inhibitor (IKK-2 inhibitor
IV), p38 MAPK (SB202190) and ERK kinase MEK-1 (U1026).
The IKK inhibitor significantly attenuated the expression of IL-6
mRNA and protein (Figures 7.3A and 7.4A) as well as IL-8 mRNA
and protein (Figs. 7.3B and 7.4B) induced by P. gingivalis LPS1690
and E. coli LPS. The p38 MAPK inhibitor blocked, to a different
extent, P. gingivalis LPS1690- and E. coli LPS-stimulated expression
of IL-6 and IL-8 (Figs. 7.3 and 7.4). ERK inhibitors did not
significantly affect the expression of these cytokines induced by P.
gingivalis LPS1690; while, ERK was significantly involved in E. coli
LPS-induced expression of IL-6 protein (Fig. 7.4A) as well as IL-8
mRNA and protein (Figs. 7.3B and 7.4B). These data revealed
that NF-kB and likely p38 MAPK signaling pathways may play a
crucial role in P. gingivalis LPS1690 induction of pro-inflammatory
cytokines, which was different from E. coli LPS where NF-kB, p38
MAPK and ERK transduction pathways were, to a different
extent, significantly involved in induction of the cytokine
expression.
Discussion
It is evident that LPS as the prototypical endotoxin from gram-
negative bacteria is highly potent in inducing innate host response
[40]. Over the years, the crucial role of P. gingivalis LPS in the
pathogenesis of periodontal disease has been intensively investi-
gated [3,4,6,10–19]. Whereas, the exact cell surface receptor for P.
gingivalis LPS has long been a subject of intense debates, as some
studies show the involvement of TLR4, whereas others argue it to
be TLR2 [24,41,42]. Similar controversy exists over the major
signal transduction pathways involved in immuno-inflammatory
response to P. gingivalis LPS, as some suggest it to be NF-kB
pathway whilst others propose the role of MAPK signal
transduction [30]. Complicating this issue further, some studies
indicate the involvement of both NF-kB and MAPK pathways as
well as other additional signal pathways like JNK or AKT [14].
The discovery of lipid A heterogeneity of P. gingivalis LPS and the
contrasting biological activities of its different isoforms, including
LPS1435/1449 and LPS1690, shed new light on this confounding
issue [28,42,43]. In an in vivo study in mice, the two isoforms
stimulated local and systemic inflammatory responses in a different
manner, presumably due to the complex nature of the local and
Table 1. List of genes upregulated (fold changes $1.5;
highlighted in bold) and downregulated (fold changes #0.5;
highlighted in italics) by P. gingivalis LPS1435/1449 and P.
gingivalis LPS1690.
Genes P. gingivalis LPS1435/1449 P. gingivalis LPS1690
CCL2 0.58 3.25
CXCL10 0.21 17.27
G-CSF 0.67 14.91
GM-CSF 0.28 26.77
IL6 0.06 11.93
IL8 0.35 8.64
HRAS 4.66 6.74
HSPA1A 1.28 2.56
TLR2 0.24 1.48
TLR4 2.04 3.14
CD14 0.45 2.26
IKBKB 1.73 2.18
NFKB1 1.48 3.55
NFKBIA 0.95 4.25
MAP2K4 1.38 2.55
MAP3K7IP1 1.61 2.1
MAP4K4 1.37 1.71
MAPK8 1.25 1.99
IRAK2 0.68 2.25
doi:10.1371/journal.pone.0058496.t001
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systemic host responses [44]. Moreover, it has been observed that
TLR2 could be an important determinant in response to P.
gingivalis in vivo [45] and induce inflammatory destruction of bone
in mice [46]. In addition, studies using P. gingivalis as a whole
bacterium have shown CD14-TLR1-TLR2 complex is important
to gain access to the cells [47]. Regarding the in vitro studies, there
is a lack of consistently strong evidence on the cell surface
receptors and signal transduction pathways that are involved in the
interaction of heterogeneous P. gingivalis lipid A structures in host
cells such as HGFs [14,24,30,41,42]. The present study attempted
to examine the effects of P. gingivalis LPS1435/1449 and LPS1690 on
the expression of TLR 2 and TLR4, downstream signal pathways
involved and the expression of pro-inflammatory cytokines in
HGFs.
Our present study revealed that LPS containing penta- and
hexa-acylated lipid A structures, which were represented by P.
gingivalis LPS1690 and E. coli LPS, upergulated strong expression of
TLR4 in HGFs in both dose- and time-dependent manners,
although the former also activated the expression of TLR2. On the
other hand, tetra-acylated P. gingivalis LPS1435/1449 predominantly
upregulated the expression of TLR2, and weakly increased the
expression of TLR4. These observations were further confirmed
by western blot analysis and confocal immuno-fluorescence
microscopy. Blocking assays demonstrated that TLR4 was a
critical receptor in immuno-inflammatory response to penta-
acylated P. gingivalis LPS1690 and hexa-acylated E. coli LPS.
Moreover both forms of LPS activated NF-kB, p38 MAPK and
ERK pathways, but not the SAPK/JNK pathway. Additionally, E.
coli LPS could activate AKT signal. On the contrary, P. gingivalis
LPS1435/1449 activated to a different extent p38 MAPK and
ERK1/2 signals. Taken together, these findings demonstrated that
P. gingivalis LPS stimulated an overall different expression profile of
TLR2 and TLR4 as well as the downstream signaling from that
stimulated by the canonical E. coli LPS. It has been shown that five
of the six fatty acid chains of E. coli LPS lipid A could occupy the
pocket created by TLR4-MD2 complex that was crucial for TLR4
dimerization and activation of subsequent signaling pathways [40].
As P. gingivalis LPS1690 and LPS1435/1449 differentially stimulated
the expression profiles of TLR2 and TLR4, the tetra-acylated lipid
A structure of the latter might either fill the space available in the
pocket or make varied changes to the complex by nullifying the
effect of corresponding LPS ligand [40]. Further investigation is
required to clarify this point.
Moreover, we also found that P. gingivalis LPS1690 induced the
nuclear translocation of p-p65, which is critical in the optimal
transcription of NF-kB-dependent genes such as IL-6 and IL-8
[48]. Further blocking assays confirmed that NF-kB pathway
played a dominant role in induction of IL-6 and IL-8 in HGFs in
response to P. gingivalis LPS1690 and E. coli LPS. These findings
could be further discussed in the context of existing literature on
the interaction between P. gingivalis LPS and host cells. Interaction
of P. gingivalis LPS with human embryonic kidney cells involves
both TLR2 and TLR4, whereas Salmonella minnesota LPS is only
sensed by TLR4 [28]. Incidentally, later studies reveal that
aforementioned P. gingivalis LPS could be a mixture of both tetra-
and penta-acylated lipid A structures [31]. Hence, the biological
activity of penta-acylated lipid A structure of P. gingivalis LPS seems
to mimic that of canonical hexa-acylated lipid A structure of E. coli
LPS. It has been demonstrated that penta-acylated lipid A
molecules from various Gram-negative bacteria can interact with
TLR4, compete and antagonize the action of hexa-acylated E. coli
LPS [49]. A similar line of observations has been made with
heterogeneous lipid A structures of P. gingivalis LPS that antagonize
the inflammatory response by competing for TLR4 occupation in
human umbilical vein endothelial cells (HUVECs) [50]. On the
other hand, some studies have shown that TLR2 receptor could be
involved in host cell recognition of P. gingivalis LPS [28,51,52]. The
expression of IL-6 in cementblasts in response to P. gingivalis
LPS1690 and P. gingivalis LPS1435/1449 is inhibited by blockage of
TLR2, but not TLR4 [51]. There is a strong activation of NF-kB
pathway in response to P. gingivalis LPS1690 with reference to a
weak activation of P. gingivalis LPS1435/1449, illustrating the
significant role of lipid A structure in activation of NF-kB
pathway. The host response of dental pulp cells to P. gingivalis
LPS is also elicited via TLR2/IKK signal transduction axis [53].
Although, it seems that P. gingivalis LPS, being different from
canonical E. coli LPS, may have some propensity to bind TLR2,
some have previously argued that it could be due to the
contamination of lipoprotein or other components during LPS
extraction. However, recent studies demonstrated that highly
purified P. gingivalis LPS facilitates activation of both TLR2 and
TLR4 in various host cell types [28]. In addition, extensively
purified P. gingivalis LPS stimulates TLR2 expression [23,54,55]. A
study has compared the functional effects of highly purified
endotoxins from E. coli, P. gingivalis, Pseudomonas aeruginosa and
Bacteroides fragilis in HUVECs and coronary artery endothelial cells
(HCAECs). It shows that HCAEC’s which express TLR2 are
responsive to LPS from species other than E. coli. It is therefore
conceivable that E. coli LPS solely utilizes TLR4, whilst LPS from
other bacterial species may utilize TLR2 as well [55]. Taking data
from foregoing studies and the data derived from the present study
into consideration, it shows that although both isoforms of P.
gingivalis LPS could activate TLR2 expression, P. gingivalis LPS1690
is a strong activator of TLR4 expression, whereas P. gingivalis
LPS1435/1449 is just a weak agonist for TLR4. The hexa-acylated
E. coli LPS is then a potent agonist for TLR4.
Previous studies have reported that P. gingivalis LPS1690 could be
a strong inducer for NF-kB pathway through TLR4 signaling in
HEK293 cells and endothelial cells [56]. In contrast, P. gingivalis
LPS1435/1449 does not elicit a significant immuno-inflammatory
activity [56,57]. We have recently demonstrated that P. gingivalis
LPS1690 is an active inducer of pro-inflammatory cytokines in
HGFs, whilst P. gingivalis LPS1435/1449 is unable to activate the
response [33]. Findings of the present study may explain the
mechanism behind this observation. Hence, P. gingivalis LPS1435/
1449 that does not strongly activate TLR4 expression and NF-kB
signals is less potent for immuno-stimulation as compared to the
more potent isoform of penta-acylated P. gingivalis LPS1690,which
significantly activates NF-kB pathway similar to that of E. coli LPS.
This notion may explain the ability of hexa-acylated E. coli LPS
Figure 4. P. gingivalis (Pg) LPS1690 (PgLPS1690) and E. coli LPS activated the NF-kB pathway in HGFs. Kinetics of IkBa and NF-kB p65
phosphorylation in HGFs are shown in 4.1 and 4.2, respectively. Cells were treated with PgLPS1435/1449 (A), PgLPS1690 (B) and E. coli LPS (C) at 1 mg/mL
for the indicated period of time. Cell extracts were prepared and the levels of IkBa, phospho-IkBa, NF-kB p65, phospho-NF-kB p65 were determined
by western blotting. Equal loading, for each treatment, was confirmed by stripping away the immunoblot, then re-probing it for a-Tubulin.
Quantification of band intensities was performed by densitometry analysis using Image J software. The values for fold increase of phospho- IkBa
(4.1D) and Phospho-NF-kB p65 (4.2D) as compared with the total protein are shown in the graphs (arbitrary units over control after normalization to
the total protein). The data shown here are from a representative experiment repeated three times with similar results. *Significant difference with a
p-value ,0.05 as compared with the controls without LPS treatment.
doi:10.1371/journal.pone.0058496.g004
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and penta-acylated P. gingivalis LPS1690 to induce the NF-kB
pathway and its downstream pro-inflammatory cytokines in a way
different from the tetra-acylated P. gingivalis LPS1435/1449.
Our study shows that E. coli LPS and P. gingivalis LPS1690, to a
different extent induced CD14 expression in HGFs. Although
CD14 is known as a receptor for LPS binding, its precise role in P.
gingivalis LPS-host interaction remains undefined [14,28,36,58].
Some have reported that HGFs do not express membrane-bound
CD14 whilst others show the reverse [59,60]. Hence, CD14 may
not critically involve in the interaction of HGFs with P. gingivalis
LPS with reference to toll-like receptors as shown above. The
observation that LBP mRNA is significantly upregulated in E. coli
LPS treated HGFs as compared to cells treated with P. gingivalis
LPS corroborates the previous finding that the binding capacity of
E. coli LPS to LBP is much stronger than binding of P. gingivalis
LPS [23].
Our current findings on structure-function relationship of LPS
lipid A component have both biological and clinical implications.
Conventionally, it is assumed that hexa-acylated lipid A from
canonical E. coli LPS is bound to LBP, which is transferred to
CD14 and then to TLR4/MD2 complex. This receptor binding
subsequently triggers oligomerization and translocation of NF-kB
into the nucleus, leading to secretion of pro-inflammatory
cytokines [61]. However, structural variation of lipid A molecule
could bring about different types of biological interaction of LPS
with host cells. Previous studies have shown that modification of
canonical E. coli lipid A structure, by replacing C12 fatty acid
(laurate) with long-chain C16 (palmitate), results in less potent LPS
Figure 5. P. gingivalis (Pg) LPS (PgLPS) and E. coli LPS activated the MAPK pathway in HGFs. Kinetics of P38 mitogen activated protein
kinase (P38 MAPK), extracellular signal-regulated kinase1/2(ERK1/2), and Stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK)
phosphorylation in HGFs are shown in 5.1, 5.2 and 5.3, respectively. Cells were treated with PgLPS1435/1449 (A), PgLPS1690 (B) and E. coli LPS (C) at
1 mg/mL for the indicated period of time. Cell extracts were prepared and the levels of P38 MAPK, phospho-p38MAPK, ERK, phospho-ERK, JNK and
phospho-JNK were determined by western blotting. Quantification of band intensities was performed by densitometry analysis using Image J
software. The fold increase values of phospho-protiens of P38 MAPK (5.1D), ERK1/2 (5.2D) and SAPK/JNK (5.3D) as compared with the total protein are
shown in the graphs (arbitrary units over control after normalization to the total protein). Equal loading was confirmed by stripping the immunoblot
and re-probing it for a-Tubulin. The data shown here are from a representative experiment repeated three times with similar results. *Significant
difference with a p-value ,0.05 as compared with the controls without LPS treatment.
doi:10.1371/journal.pone.0058496.g005
Figure 6. Confocal images of p-p65 NF-kB nuclear translocation in LPS treated HGFs. The cells were left untreated (A) or stimulated with P.
gingivalis (Pg) LPS1435/1449 (PgLPS1435/1449) (B), PgLPS1690 (C) and E. coli LPS (D) (1 mg/ml) for 15 min (6.1) and 60 min (6.2), respectively. Cells were
permeabilized with 0.1% Triton X-100 and subsequently stained with primary antibodies against anti-phospho p65-NF-kB and the correspondent
secondary antibody labeled Alexa fluor 488 anti-rabbit, and subsequently stained with alexa fluor 555 phalloidin for F-Actin. The cytoplasmic p-p65
NF-kB appears in green color and F-actin is shown in red color. Negative control: E. The arrow heads show the prominent nuclear staining in the
nucleus. Merged 1 images present the combined p-p65- NF-kB and F-actin, whereas Merged 2 images show the combined p-p65-NF-kB, F-actin and
nuclear staining which is counterstained with DAPI. The experiment was performed three times, and the pictures observed correspond to a
representative field for each of the times studied. Scale bar = 100 um.
doi:10.1371/journal.pone.0058496.g006
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Figure 7. Blocking assay on the involvement of TLR2/TLR4 and signal transduction pathways in P. gingivalis (Pg) LPS1690
(PgLPS1690)- and E. coli LPS-induced expression of IL-6 and IL-8 in HGFs. The cells were pretreated for 1 h with anti-TLR2 and anti-TLR4
antibodies in serum free medium, and then treated with PgLPS and E. coli LPS at 1 mg/ml for additional 12 h. Total RNA and cell culture supernatants
were collected and analyzed for IL-6 (A) and IL-8 (B) by quantitative real-time PCR and ELISA, respectively. The histograms show IL-6 (7.1A) and IL-8
(7.1B) mRNA levels of three independent experiments, and IL-6 (7.2A) and IL-8 (7.2B) protein expression levels of two independent experiments. The
results were presented as mean 6SD. Calculation of significant difference were made in comparison to the controls without LPS treatment (*p-value
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[62]. Hence, length and number of fatty acid chain could
significantly modulate the activation of host signal transduction
and the resultant immuno-inflammatory response [43,62,63]. The
present study demonstrates that structural heterogeneity in P.
gingivalis LPS lipid A is a critical determinant of host cell sensing
and signaling towards pathogens. The molecular conformation of
lipid A structure has been shown to influence the supra-molecular
structure of LPS, i.e. cylindrical lipid A generates lamellar
structures whilst conical lipid A forms cubic or hexagonal
structures [64,65]. Therefore, three-dimensional arrangement of
lipid A is a crucial determinant of LPS activity. As the number of
attached fatty acid chains in the lipid A decreases, so does the
potency of LPS. E. coli lipid A. So with a conical shape consisting
of six asymmetrical acyl chains, E. coli lipid A is a potent activator
of immuno-inflammatory response, while P. gingivalis LPS lipid A
comprising of four-acyl chains such as, P. gingivalis LPS1435/1449
has strictly cylindrical conformations, which result in relatively
weak activity to induce host response. Not only periodontal
pathogens like P. gingivalis, but also other Gram-negative bacterial
species such as Rhodobacter capsulatus or Chromobacterium violaceum
contain tetra-acylated lipid A structures which are weak inducers
of pro-inflammatory mediators like IL-6 [66].
Three-dimensional conformation due to variation in lipid A
structure could elegantly explain the differential biological activity
of P. gingivalis LPS lipid A component, in terms of receptor binding
and subsequent activation of signal transduction cascades. For
instance, conical shape E. coli LPS bearing hexa-acylated lipid A
exclusively binds to TLR4, whereas less conical or more
cylindrical PgLPS1690 may interact with TLR2 and/or TLR4.
However, P. gingivalis LPS1690 may preferentially bind to TLR4 as
five fatty acid chains are sufficient to fully occupy the TLR4
binding pocket as observed previously [40]. In contrast, P. gingivalis
LPS1435/1449,which has strictly cylindrical shape with four fatty-
acid chains, might to some extent occupy TLR2 [67]. However,
further investigation is required to confirm these points.
P. gingivalis possesses multiple mechanisms for the binding and
uptake of hemin into the periplasmic and cytoplasmic compart-
ments. Hemin concentration in the vicinity may transduce
conformational changes in P. gingivalis LPS via regulation of
hemin receptors or modification of phosphatases [68]. It has also
been shown that P. gingivalis grown in high hemin conditions
produces predominantly the isoform of LPS with tetra-acylated
lipid A structure containing 4-phosphate group, i.e. P. gingivalis
LPS1435/1449. In contrast, under low hemin conditions P. gingivalis
produces the isoform of LPS with penta-acylated lipid A structure,
i.e. P. gingivalis LPS1690 [56]. Hence, certain micro-environmental
conditions like high hemin concentration during inflammation
may promote P. gingivalis to shift its LPS from the predominant
penta-acylated lipid A structure towards more tetra-acylated one.
This lipid A transformation has been observed in both laboratory
and clinical isolates of P. gingivalis [68]. Therefore, it has been
suggested that shifting LPS into tetra-acylated lipid A structure
may dampen the TLR4-mediated immuno-inflammatory response
of gingival tissues, allowing the adaptive pathogen to invade and
proliferate in the gingival tissues, thereby leading to progression of
periodontal disease. This phenomenon has also been seen in other
Gram-negative bacteria such as Yersinia pestis, which modifies its
lipid A structure from hexa-acylated to a tetra-acylated lipid A
during the transition from 27uC to 37uC [69]. This deacylation
process bestows the ability of bacterial LPS to dampen the host
immune response. Structural modulation of lipid A in other Gram-
negative bacteria such as P. aureginosa has important clinical
implications as well [70].
Within the limitations of the study, the present findings are
consistent with other observations [71–73], which demonstrates
that the tetra- and penta-acylated lipid A structures of P. gingivalis
LPS interact differentially with TLR2 and TLR4, and critically
determine the subsequent activation of the downstream signal
transduction cascade that differentially modulates immuno-
inflammatory response. This reflects the critical importance of
lipid A structural heterogeneity of P. gingivalis LPS in activation of
TLR receptors and their downstream signal transduction path-
ways in P. gingivalis-host cell interactions. It could be postulated
that the ability to alter the lipid A structure of LPS may be a
crucial strategy adopted by P. gingivalis as a keystone periodontal
pathogen to evade innate host defense, thereby contributing to
periodontal pathogenesis. The present study sheds new light on
what is currently known about the interactions of host cells like
HGFs with heterogeneous isoforms of P. gingivalis LPS, and
contributes to further understanding of the pathogenesis of
bacteria-induced inflammatory diseases like periodontal disease,
and developing novel preventive and therapeutic approaches to
controlling these diseases.
Experimental Procedures
Preparation and Purification of P. gingivalis LPS
P. gingivalis LPS was isolated from P. gingivalis ATCC 33277
strain using cold MgCl2-ethanol (EtOH) procedure as described
previously [28,43]. LPS purification was undertaken using TRI
Reagent approach, as documented previously [74]. Crude LPS
was subjected to modified Folch extraction to remove phospho-
lipids and further treated to remove trace amounts of endotoxin
proteins preparations detected by enhanced Colloidal gold
staining [43]. Lipid A was purified using mild acid hydrolysis as
described previously, and the total fatty acid content of LPS was
analyzed by Gas chromatography (GC) [75]. Extracted lipid A was
then analyzed by negative ion MALDI-TOF MS for the structural
determination of lipid A observed [28,43]. Two detected ion peaks
that were clusterd around a mass of 1690 and 1435/1449
designated as penta-acylated P. gingivalis LPS1690 and tetra acylated
P. gingivalis LPS1435/1449, respectively. Highly purified E. coli LPS
(JM 83 wild type strain) served as positive control.
HGF Cell Culture
Primary HGFs were purchased from Sciencell research
laboratories (Carlsbad, CA, USA) and cultured according to the
manufacturer’s instructions. Cells were suspended in fibroblast
medium consisting of the basal medium, 2% Fetal Bovine Serum
(FBS), fibroblast growth supplement (FGS) and 2% penicillin/
streptomycin (P/S), and then incubated with an atmosphere of 5%
CO2 and 95% air at 37uC [33,76]. The cultured cells at 3–4
passages, with spindle shaped morphology, were designated as
appropriate for the following experiments.
,0.05) or the cells treated with LPS alone (#p-value ,0.05). Cells were pretreated with IKK-2 inhibitor IV (IKK-b inhibitor), SB202190 (p38 MAPK
inhibitor) and U0126 (ERK inhibitor) in serum free medium for 1 h, then treated with PgLPS and E. coli LPS at 1 mg/ml for additional 12 h. The
histograms show IL-6 (7.3A) and IL-8 (7.3B) mRNA levels of three independent experiments, and IL-6 (7.4A) and IL-8 (7.4B) protein expression levels of
two independent experiments. The results were presented as mean6SD. Calculation of significant difference were made in comparison to the
controls without LPS treatment (*p-value ,0.05) or the cells treated with LPS alone (#p-value ,0.05).
doi:10.1371/journal.pone.0058496.g007
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LPS Stimulation
HGFs were cultured in six-well plates with 16105 cells per well.
While reaching 95% confluence, FM medium was replaced with
acf-FM for subsequent dose- and time-dependent experiments. In
the dose-dependent assay, cells were stimulated with P. gingivalis
LPS1435/1449, P. gingivalis LPS1690 or E. coli LPS at various doses
(1 ng/ml–10 mg/ml). Based on the results, 1 mg/ml was selected as
the appropriate dose for the subsequent time-dependent experi-
ments. In the time-dependent assays, cells were treated with 1 mg/
ml of P. gingivalis LPS or E. coli LPS and incubated for different
period of time (2–48 h). Cells without LPS treatment were taken as
the controls. Culture supernatants were collected and centrifuged
to remove the cell debris and stored in -70uC until further use. The
attached cells were then washed with PBS and subjected to RNA
and protein extraction, respectively. Total proteins were extracted
by using Mammalian protein extraction buffer plus protease and
phosphatase inhibitors (Pierce, Thermo Scientific, USA). Cell
lysates were collected and centrifuged at 14,000 rpm at 4uC for
15 min to remove the cell debris. The protein concentration was
then measured in both cellular proteins and culture supernatants
using BCA protein assay kit (Pierce, Thermo scientific, USA).
Transcriptomic Analysis of TLR Signaling Pathway using
PCR-array
In order to explore the holistic view of gene expression in HGFs,
upon treatment with P. gingivalis LPS1435/1449 and LPS1690, a panel
of 84 genes related to TLR signaling pathway was examined using
RT2 profiler PCR arrays (PAHS 018C, SA biosciences, Frederick,
MD, USA). The complete description of the analyzed genes was
listed in Table S2. In order to ensure the high quality of cDNA,
reverse transcription reactions were performed using RT2 First
Strand Kit according to the manufacturer’s protocol (SuperArray,
Frederick, MD, USA). Diluted cDNA template was mixed with
RT2 qPCR Master Mix (SYBR Green/Rox, SA Biosciences) and
RNAse-free water (SuperArray Bioscience Corp, Frederick, MD,
USA). Then 25 mL of the experimental cocktail were aliquoted to
each well of the 96-format PCR array plate containing pre-
dispensed gene specific primers. Finally, mRNA was amplified on
a StepOne Real-Time PCR system (ABI, Foster City, CA, USA),
using the following amplification procedure. After the initial
incubation at 95uC for 10 min, 40 cycles of amplification was
accomplished with 15 s at 95uC for denaturation and 1 min at
60uC for annealing, respectively. To check the differential
expression of related genes, each run was performed in duplicates
with reference to the controls. To ensure the reliability, reverse
transcription controls (RTC), positive controls (PPC) and genomic
DNA controls (GDC) were included in the experiments. The
instrument’s software calculated the threshold cycle (Ct) values for
all genes tested in the array. Finally, the fold changes in gene
expression were calculated for pairwise comparison using the
DDCt method from the raw threshold cycle data 2010 [77]. Gene
expression was considered up-regulated (fold-changes .1.5) or
down-regulated (fold-changes ,0.5), and the analysis was carried
out using the SA biosciences web-based PCR array data analysis
software (SA Biosciences, Frederick, MD, USA).
Evaluation of Candidate Genes by Real-time qPCR
Real-time qPCR was performed to further examine the
candidate genes related to TLR pathway. Total RNA extraction,
cDNA synthesis and RT-PCR reaction were performed as
mentioned previously [33]. Total RNA was extracted by using
RNeasy mini kit (Qiagen, USA) and the RNA concentration was
quantified by using the NanoDrop spectrophotometer (Thermo,
USA). The extracted RNA was then subjected to cDNA synthesis
by using reverse transcriptase-PCR described elsewhere [26]. Q-
RT-PCR was performed in StepOne Real-Time PCR System
(Applied Biosystems, USA) in at least three separate experiments.
Amplification reactions were performed in a final volume of 20 ml
containing 10 ml of Power SYBR_Green PCR MasterMIx
(Applied Biosystems), 1 ml of cDNA tempelate and 1 ml of each
pairs of primers (Sigma). Real-time primer pairs were designed
using primer 3 software (NCBI, USA) (Table S3). The amplifica-
tion efficiencies of the primers used were above 90%. Real-time
qPCR reaction conditions were set at 95uC for 10 min followed by
40 cycles at 95uC for 15 s and 60uC for 1 min. The expression
level of each gene was normalized to a b-actin (Ct) and fold-
changes for each gene were calculated by comparing the LPS-
treated test and untreated controls from the Ct values according to
the Ct approach [26,33].
Detection of TLRs Expression by Confocal
Immunofluorescence Microscopy
HGFs were seeded on 12 mm circular cover slips in six-well
plates (16106 cells/well) and cultured overnight in order to
achieve over 80% confluent. Afterwards, cells were incubated with
1 mg/ml of either P. gingivalis LPS1435/1449, P. gingivalis LPS1690 or
E. coli LPS for 6 h and 24 h. Cells without any stimulus were taken
as controls. After LPS stimulation, cover slips were washed twice in
PBS and fixed with 4% (V/V) paraformaldehyde in PBS for
15 min at room temperature. The cover slips were then washed
three times in PBS, and permeabilized by treatment with 0.1%
Triton X-100 in PBS for 10 min. Following washing three times in
PBS, and blocked with PBS containing 3% bovine serum albumin
(BSA), plus Tween 20 (0.1% v/v), blocking buffer for 30 min at
room temperature, cells were then incubated overnight at 4uC
with blocking buffer containing the primary antibodies for TLR4
(polyclonal anti-rabbit TLR4 antibody, 1:100, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and TLR2 (monoclonal
mouse anti-human TLR2 antibody, 1:100, Abcam). Cells were
then washed with 0.1% BSA-PBS and incubated in blocking buffer
containing corresponding secondary antibodies (anti-rabbit or
anti-mouse IgG conjugated with Alexa fluor 488, 1:200) for 1 h at
room temperature, and excess stain was rinsed off by PBS washes.
The cell contour stained for F-actin was detected after 20 min
incubation by phalloidin conjugated Alexa fluor 555 (1:40,
Invitrogen, Eugene, Oregone, USA). Next, cells were washed
with PBS/TBS and visualized on a confocal laser-scanning
microscope (Olympus Fluoview FV 1000; Olympus, Tokyo,
Japan) using FV10-ASW 3.0 software for image analysis. For
detection of cell nuclei, cells were stained with DAPI (496-
diamidino-2- phenylindole, dilactate, Invitrogen, USA). Cells
treated with IgG isotype control (R & D systems) instead of the
primary antibody served as the negative control.
Pathway-focused Western Blot Analysis
Western blot analysis was performed to examine the expression
of TLR2, TLR4 and other key molecules related to major signal
transduction pathways such as p-IkBa, p-p65, p-p38 MAPK, p-
ERK, p-JNK and p-AKT. HGFs were serum starved for 24 h and
then stimulated with 1 mg/ml of P. gingivalis LPS1435/1449, P.
gingivalis LPS1690 or E. coli LPS, for 5, 15, 30, 60 and 120 min.
Western blots were performed according to the standard protocol,
which were used in previous studies [78]. All the pathway
molecules were examined using repeated stripping technique for
each blot, in order to minimize the batch-to-batch variation.
Initially, each blot was probed for phosphorylated proteins,
followed by stripping and re-probing with the appropriate probe
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for total proteins. a-Tubulin was used as the internal loading
control. In brief, 40 mg of protein lysates were separated by 10%
SDS-PAGE and transferred onto PVDF (Polyvinylidene difluor-
ide) membranes (Roche, USA) by using the Mini-PROTEAN
Tetra electrophoresis system and the Mini Trans-Blot transfer
system (Bio-Rad, USA). Following the transfer, blots were blocked
with protein-free T20 (TBS) blocking buffer (Thermo scientific,
USA) at room temperature for 1 h and incubated with primary
antibody at 4uC while shaking overnight. Primary antibodies were
all obtained against monoclonal rabbit anti-human antibodies;
TLR4 antibody (1:1000, Santa Cruz), TLR2 antibody (1:1000,
Cell Signaling), phospho IkBa (pIkBa)(1:1000, Cell Signaling),
IkBa antibody (1:1000, Cell Signaling), phospho NF-kB p65
(1:1000, Cell Signaling), NF-kB p65 (1:1000, Cell Signaling),
phospho-p38 antibody (pP38MAPK) (1:1000, Cell Signaling),
p38MAPK antibody (1:1000, Cell Signaling), phospho-SAPK/
JNK p-JNK antibody (1:1000, Cell Signaling), SAPK/JNK
antibody (1:1000, Cell Signaling), phospho-ERK1/2 antibody
(1:2000, Cell Signaling), ERK1/2 antibody (1:1000, Cell Signal-
ing), phospho-AKT antibody (1:1000, Cell Signaling), and AKT
antibody (1:1000, Cell Signaling). a-Tubulin (1:2000, Cell
Signaling) was used as the internal loading control. After being
washed with the washing buffer, the blots were incubated with
horseardish peroxidase (HRP) conjugated goat-anti-rabbit IgG
(1:10000, Cell Signaling) at room temperature for 1 h, then the
bound immune-complexes were detected using ECL reagent
(super signal west pico chemiluminescent kit, Thermo Scientific,
USA). Detected bands were scanned on a calibrated densitometer
(GS-800, Bio-Rad, Hercules, CA, USA) and the integrated density
of each band was quantified using Image J software-based analysis
(http://rsb.info.nih.gov/ij/).
Analysis of NF-kB Nuclear Translocation
Activation and translocation of NF-kB were observed by
confocal immunofluorescence assay as mentioned previously.
After LPS stimulation for 15 and 60 min, cells were fixed, blocked
and incubated with rabbit anti-phospho NF-kB p65 (1:100, Cell
Signaling) over night at 4uC. After three washes in 0.1% BSA-
PBS, the cells were incubated with FITC conjugated goat anti-
rabbit secondary antibody at room temperature for 60 min. After
rinsing in PBS, cells were counterstained with DAPI (10 mg/ml)
for 5 min. The slides were then washed, air-dried and mounted
with fluorescent mounting medium and visualized on a confocal
laser-scanning microscope (Olympus Fluoview FV 1000; Olym-
pus, Tokyo, Japan) using FV10-ASW 3.0 software for image
analysis. Negative controls were established by omitting primary
antibody.
Blocking Assays of TLR2 and TLR4
Neutralization of TLRs was achieved by using TLR-specific
blocking antibodies. HGFs were grown in six-well tissue culture
plates until 90% confluent as described above. Then the cells were
incubated for 1 h with serum free fresh media containing 20 mg/
ml of anti-human TLR2 antibody (eBioscience, San Diego, USA)
and 20 mg/ml of anti-human TLR4 antibody (eBioscience) using
20 mg/ml of mouse IgG2a isotype control (Biolegend, San Diego,
CA, USA) as the negative control, prior to the addition of LPS.
Afterwards, cells were challenged with 1 mg/ml of either P.
gingivalis LPS1435/1449, P. gingivalis LPS1690 or E. coli LPS for 12 h.
Cells incubated with medium alone was considered as the negative
control, while cells incubated with LPS without prior incubation
with TLR antibody were used as the positive control. After
stimulation, culture media supernatants were collected for cytokine
assays and the cells were harvested for extraction of total mRNA.
Blocking Assays of Signal Transduction Pathways
The functional roles of NF-kB, p38 MAPK and ERK involved
in the interactions of HGFs with P. gingivalis LPS1690 or E. coli LPS
were examined using pathway-specific kinases inhibitors. To block
the specific kinase activity, cells were pretreated with following
specific kinase inhibitors for 1 h before stimulation with LPS:
10 mmol/L of the IKK-b inhibitor, IKK-2 inhibitor IV (Merck,
USA), 10 mmol/L of the p38 MAPK inhibitor, SB202190
(Calbiochem Biosciences Inc, La Jolla, CA, USA), and 15 mmol/
L of the ERK (MEK1) inhibitor, U1026 (Cell Signaling). Each
inhibitor was dissolved in DMSO and diluted in DPBS.
Afterwards, LPS was added to the medium and cells were
incubated for another 12 h. Culture media supernatants and RNA
were used for ELISA and real-time qPCR analysis, respectively.
Cells incubated only with LPS, without adding any kinase
inhibitors, were regarded as positive controls, whereas those
treated with culture medium alone served as the negative controls.
To examine the effects of these inhibitors on the basal expression
of cytokines, cells were treated with kinase inhibitors alone.
Assay of IL-6 and IL-8 by ELISA
The expression profiles of IL-6 and IL-8 were analyzed in
culture supernatants using specific human ELISA kits (DuoSet,
R&D Systems, Minneapolis, MN, USA) in triplicates following the
manufacturer’s instructions. The minimal detectable concentra-
tions of IL-6 and IL-8 were 0.70 pg/ml and 3.5 pg/ml,
respectively. No cross-reactivity or interference was observed with
recombinant IL-6 and IL-8. The absorbance values for the ELISA
assays were determined by a microplate reader (Victor, Vienna,
VA, USA) at an optical absorbance of 450 nm. The final
concentration was determined with reference to a standard curve.
Statistical Analysis
All experiments were repeated in at least three assays for real-
time qPCR, western blot and two assays for ELISA. All values
were presented as the mean 6SD. The statistical significance of
difference between the data sets from the dose-dependent assay
was evaluated by student t-test, one-way analysis of variance
(ANOVA) and post-hoc testing with Bonferroni and LSD
methods, as appropriate. Additionally, repeated measures AN-
OVA were used to determine the differences between data sets
from the time-dependent assay. A p-value ,0.05 was considered
statistically significant. All statistical analysis was performed using
a software program (SPSS 19.0, SPSS Inc, Chicago, IL, USA).
Supporting Information
Figure S1 Confocal images of TLR2 (S1.1) and TLR4
(S1.2) expression in HGFs following LPS stimulation for
24 h. HGFs were left untreated (A) or stimulated with 1 mg/ml of
P. gingivalis (Pg) LPS1435/1449 (PgLPS1435/1449) (B) PgLPS1690 (C)
and E. coli LPS (D). Negative control: E. Cells were then
permeabilized with 0.1% Triton X-100 and subsequently stained
with primary antibodies against TLR2, TLR4 and the correspon-
dent secondary antibody labeled Alexa fluor 488 anti-rabbit, and
subsequently stained with alexa fluor 555 phalloidin for F-actin.
Merged images present the combined TLR2 or TLR4, F-actin,
and nuclear staining (DAPI). One representative experiment from
three independent experiments is shown. Bar = 50 mm or 100 mm.
(TIF)
Figure S2 P. gingivalis (Pg) LPS -induced gene expres-
sion of inflammatory mediators in HGFs. The cells were
treated with PgLPS at 1 mg/mL or culture medium alone for 24 h.
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Total RNA was extracted and reverse transcribed into cDNA
templates. The templates used in PCR array were pooled equally
from triplicate samples. Representative heat maps showing the
fold-changes of each gene in PgLPS1435 (A)- and PgLPS1690 (B)-
treated HGFs with reference to the controls. Genes that were
upregulated over 2 folds are shown in red color and those down
regulated by 0.5 folds are shown in green color.
(TIF)
Figure S3 P. gingivalis (Pg) LPS1690 induced the mRNA
expression of inflammatory mediators in HGFs. The cells
were stimulated with PgLPS and E. coli LPS (1 mg/mL) for 24 h.
The harvested RNA was subjected to real-time quantitative PCR
analysis. Fold increase of genes were analyzed relative to the
internal control b-Actin, including GM-CSF (A), CXCL10 (B), IL-
6 (C) and IL-8 (D). Each bar represents the mean6SD of three
independent experiments with three replicates. *Significant
difference with a p-value ,0.05 as compared with the controls
without LPS treatment.
(TIF)
Figure S4 Kinetics of protein kinase B (PKB) or AKT
phosphorylation in HGFs. The cells were stimulated with P.
gingivalis (Pg) LPS1435/1449 (PgLPS1435/1449) (A), PgLPS1690 (B) and
E. coli LPS (C) at 1 mg/mL for the indicated periods of time. Cell
extracts were prepared and the sample aliquots containing 40 mg
of protein were separated by SDS-polyacrylamide gel electropho-
resis and immunoblotted with anti-phopho AKT specific antibod-
ies. Fold increase values of p-AKT optical density (arbitrary units
over control after normalization to the loading control (total AKT)
are shown in the graphs (D). The data shown here are from a
representative experiment repeated three times with similar
results. *Significant difference with a p-value ,0.05 as compared
with the controls without LPS treatment.
(TIF)
Table S1 Differential expression profile of genes associated with
TLR signal transduction in HGF. The cells were treated with P.
gingivalis (Pg) LPS1435/1449 (PgLPS1435/1449) and PgLPS1690 (1 mg/
mL) for 24 h. After the stimulation, mRNA was extracted from
cellular fraction and reverse transcribed to cDNA. Pathway-
focused PCR gene array was adopted to analyse the cDNA
corresponding to 84 inflammation-associated genes quantified
with qRT-PCR. Relative expression was analysed comparing the
LPS treated cells with the cDNA prepared from the controls. The
fold-changes in gene expression in the P. gingivalis LPS-treated cells
versus control cells are listed. Genes that were upregulated over 2
folds are marked in red color and those down regulated by 0.5
folds are highlighted in blue color.
(DOCX)
Table S2 Genes included in the TLR signaling pathway RT-
PCR array kit (SA Biosciences). A total of 84 genes related to TLR
signaling family were analyzed, including adaptor and effector
proteins, members of the NF-kB, JNK/p38, IRF and JAK/STAT
signaling pathways as well as downstream pathway genes.
(DOCX)
Table S3 Nucleotide sequence of primers for real-time PCR.
Quantitative real time (QRT) PCR was performed using custom-
designed primers for the cell surface receptors, adaptor molecules
and pro-inflammatory cytokines using purified RNA from HGFs
stimulated with P. gingivalis LPS and E. coli LPS.
(DOCX)
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